Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 2,554 | 2,567 | 2,377 | 2,840 | 2,575 |
| Cost of Goods | 2,199 | 2,227 | 2,008 | 2,500 | 2,276 |
| Gross Profit | 354 | 340 | 369 | 339 | 300 |
| Operating Expenses | 3,082 | 839 | 428 | 962 | 640 |
| Operating Income | -2,529 | -272 | -51 | -123 | -65 |
| Other Income | -4 | -3 | -3 | -5 | -2 |
| Pre-tax Income | -2,533 | -275 | -53 | -128 | -67 |
| Income Tax | 76 | -16 | 16 | 30 | 10 |
| Net Income Continuous | -2,609 | -259 | -69 | -157 | -77 |
| Net Income | $-2,609 | $-259 | $-69 | $-157 | $-77 |
| EPS Basic Total Ops | -1.57 | -0.41 | -0.07 | -0.15 | -0.28 |
| EPS Basic Continuous Ops | -1.56 | -0.18 | -0.05 | -0.20 | -0.05 |
| EPS Diluted Total Ops | -1.57 | -0.41 | -0.07 | -0.15 | -0.28 |
| EPS Diluted Continuous Ops | -1.56 | -0.18 | -0.05 | -0.20 | -0.05 |
| EBITDA(a) | $-2,499 | $-248 | $-26 | $-97 | $-39 |